Haloperidol News and Research

RSS
Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines.
Study shows efficacy of antipsychotic as adjunctive therapy for gastroparesis in emergency department

Study shows efficacy of antipsychotic as adjunctive therapy for gastroparesis in emergency department

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

Harris Health System expert offers guidance to prevent drug-induced photosensitivity

Harris Health System expert offers guidance to prevent drug-induced photosensitivity

Powerful pain medicine may help reduce vision damage of glaucoma

Powerful pain medicine may help reduce vision damage of glaucoma

Two research studies on new molecules could potentially treat Alzheimer's disease

Two research studies on new molecules could potentially treat Alzheimer's disease

Antipsychotic drug use linked to 60% increased risk of mortality among people with Alzheimer's disease

Antipsychotic drug use linked to 60% increased risk of mortality among people with Alzheimer's disease

Measuring the activity of a mouse brain from a single snapshot

Measuring the activity of a mouse brain from a single snapshot

Schizophrenia drug slows pancreatic tumor growth in mice

Schizophrenia drug slows pancreatic tumor growth in mice

Scientists find ketamine as effective sedative for treating highly-agitated patients prior to hospitalisation

Scientists find ketamine as effective sedative for treating highly-agitated patients prior to hospitalisation

Coprophagia linked to neurodegenerative dementia

Coprophagia linked to neurodegenerative dementia

Warning of increased mortality risk for PD patients taking antipsychotics

Warning of increased mortality risk for PD patients taking antipsychotics

Antipsychotic drugs may do significantly more harm to Parkinson's disease patients

Antipsychotic drugs may do significantly more harm to Parkinson's disease patients

Brain circuit problem may contribute to auditory hallucinations of schizophrenia

Brain circuit problem may contribute to auditory hallucinations of schizophrenia

Little efficacy difference between old and new antipsychotics

Little efficacy difference between old and new antipsychotics

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Antipsychotic drug not effective in treating delirium in critically ill patients

Antipsychotic drug not effective in treating delirium in critically ill patients

Antipsychotics seemed to normalize gene expression pattern in people with bipolar disorder: Study

Antipsychotics seemed to normalize gene expression pattern in people with bipolar disorder: Study

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Two-drug combo relieves agitation first time

Two-drug combo relieves agitation first time